NASDAQ:SNESSenesTech Stock Price, Forecast & News

SenesTech's stock was trading at $2.48 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SNES stock has decreased by 19.8% and is now trading at $1.99. View which stocks have been most impacted by Coronavirus.

SenesTech is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for SenesTech.

SenesTech Inc (NASDAQ:SNES) released its quarterly earnings data on Friday, May, 15th. The company reported ($1.69) EPS for the quarter, missing the consensus estimate of ($1.46) by $0.23. The firm earned $0.04 million during the quarter, compared to analyst estimates of $0.05 million. SenesTech had a negative return on equity of 290.83% and a negative net margin of 6,193.17%. View SenesTech's earnings history.

SenesTech shares reverse split on Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 4th 2020. An investor that had 100 shares of SenesTech stock prior to the reverse split would have 5 shares after the split.

Headlines about SNES stock have trended negative on Monday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. SenesTech earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about SenesTech.

SenesTech saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 19,000 shares, an increase of 322.2% from the June 15th total of 4,500 shares. Based on an average trading volume of 311,400 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.6% of the company's stock are short sold. View SenesTech's Current Options Chain.

Some companies that are related to SenesTech include Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT) and ICL Group (ICL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Marathon Oil (MRO), McDermott International (MDR), Ring Energy (REI), Ring Energy (REI), Auris Medical (EARS), Melinta Therapeutics (MLNT), ZIOPHARM Oncology (ZIOP) and Adamis Pharmaceuticals (ADMP).

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SNES stock can currently be purchased for approximately $1.99.

SenesTech has a market capitalization of $6.75 million and generates $140,000.00 in revenue each year. The company earns $-10,020,000.00 in net income (profit) each year or ($7.69) on an earnings per share basis. SenesTech employs 40 workers across the globe.

The official website for SenesTech is www.senestech.com.

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The company can be reached via phone at 928-779-4143 or via email at [email protected]